FDA seeking nominations for mammography advisory committee

The U.S. Food and Drug Administration is looking to fill upcoming vacancies within the National Mammography Quality Assurance Advisory Committee. 

On Jan. 6, the agency put out a notice requesting nominations for prospective voting members who are well qualified to serve on the committee, which falls under the umbrella of the Center for Devices and Radiological Health. The National Mammography Quality Assurance Advisory Committee provides guidance and recommendations related to the standards by which mammography facilities are regulated.  

Most recently, the committee voted to amend a portion of the Mammography Quality Standards Act, resulting in a new rule that requires imaging facilities to inform women of their breast density status. That rule officially went into effect on Sept. 10. 

The committee consists of 15 members. To qualify, individuals must be “physicians, practitioners, and other health professionals, whose clinical practice, research specialization or professional expertise includes a significant focus on mammography,” according to the FDA. Members are allowed to serve on the committee for up to four consecutive years. 

Anyone interested in nominating themself or someone else should submit their resume, including current business address, phone number and email address, in addition to a signed copy of the FDA’s acknowledgement and consent form. If an individual is nominating someone else, the candidate must be made aware. 

The agency will begin accepting nominations on Feb. 1 and will give first consideration to those submitted prior to March 7; nominations submitted after March 7 will be considered for future vacancies as they become available. 

Anyone looking to nominate themself or someone else can do so electronically on the FDA’s Advisory Nomination Portal. 

More information on the process can be found here. 

Hannah murhphy headshot

In addition to her background in journalism, Hannah also has patient-facing experience in clinical settings, having spent more than 12 years working as a registered rad tech. She began covering the medical imaging industry for Innovate Healthcare in 2021.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.